Sino Biopharmaceutical Ltd. operates as an investment holding company, which engages in the manufacturing and selling of pharmaceutical products. The company operates through the following ...

C ARLSBAD, CA - Palisade Bio, Inc. (NASDAQ: PALI), a clinical-stage biopharmaceutical company with a market capitalization of $2.34 million, announced today the completion of the Single Ascending ...

ZURICH (Reuters) - Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical ... Poseida - equivalent to 66% of the California company's stock - which had been tendered ...